Qual é o preço para Pharnext S.A. (ALPHA)

O preço para Pharnext S.A. (ALPHA) é $0.00023723

Qual é a capitalização de mercado para Pharnext S.A. (ALPHA)

A capitalização de mercado para Pharnext S.A. (ALPHA) é $1.41K

Pharnext S.A. (ALPHA) Desdobramentos de Ações

Based in France, Pharnext SA is a clinical-stage biopharmaceutical firm dedicated to creating treatments for a range of neurodegenerative disorders, encompassing both rare (orphan) and common forms. Its pipeline features SYNGILITY, which has advanced through Phase III trials for Charcot-Marie-Tooth disease type 1A (CMT1A). Additionally, PXT864 has concluded Phase II clinical studies for Alzheimer's disease, and is also being explored for its potential in Parkinson's disease and amyotrophic lateral sclerosis (ALS). Pharnext also innovates with PLEOTHERAPY, a proprietary platform that harnesses big genetic data and artificial intelligence. In a collaborative effort, the company holds an agreement with the University Hospital Institute Mediterranee Infection to assess existing pharmaceuticals for their potential application against the COVID-19 virus. The organization was established in 2007, with its main offices located in Issy-Les-Moulineaux, France.

Ano	Desdobramento	Multiplicador	Multiplicador cumulativo
2024-02-15	1:10000	x0.0001	x4.0E-16
2023-09-18	1:5000	x0.0002	x4.0E-12
2023-05-10	1:10000	x0.0001	x2.0E-8
2022-11-23	1:5000	x0.0002	x0.0002

Ano

Desdobramento

Multiplicador

Multiplicador cumulativo

2024-02-15

1:10000

x0.0001

x4.0E-16

2023-09-18

1:5000

x0.0002

x4.0E-12

2023-05-10

1:10000

x0.0001

x2.0E-8

2022-11-23

1:5000

x0.0002

Empresa	Número de desdobramentos de ações	Multiplicador cumulativo	País
Vertex Pharmaceuticals Incorporated VRTX.US	1	x2	US
Argenx SE ARGX.US	0	-	NL
Lonza Group AG LONN.SW	0	-	CH
UCB S.A. UCB.BR	0	-	BE
Samsung Biologics Co.,Ltd. 207940.KS	0	-	KR

Empresa

Número de desdobramentos de ações

Multiplicador cumulativo

País